The Advantage in Long-Term Survival of Radiofrequency Ablation for Hepatocellular Carcinoma Patients: Historical Comparison With Ethanol Injection
β Scribed by Oeda, Satoshi ;Mizuta, Toshihiko ;Isoda, Hiroshi ;Kuwashiro, Takuya ;Iwane, Shinji ;Kawaguchi, Yasunori ;Ozaki, Iwata ;Fujimoto, Kazuma
- Book ID
- 122328072
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 367 KB
- Volume
- 140
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In most patients with cirrhosis, successful percutaneous ablation or surgical resection of hepatocellular carcinoma (HCC) is followed by recurrence. Radiofrequency ablation (RFA) has proven effective for treating HCC nodules, but its repeatability in managing recurrences and the impact of this appro
## BACKGROUND. The objective of this study was to evaluate the indications for percutaneous ethanol injection (PEI) performed in a single session under general anesthesia for treating patients with cirrhosis and large (tumors ΟΎ 5 cm) hepatocellular carcinoma (HCC), and relevant survival curves. #
For the treatment of small hepatocellular carcinoma (HCC), radiofrequency ablation (RFA) is in some centers considered a first-line therapeutic option. However, such a strategy is still under debate with regard to tumor and patient characteristics. In this single-center study we assessed the 5-year